Venture Market News for September 24, 2018
- Cannabics Pharmaceuticals Inc. Prices $7,500,000 Registered Direct Offering
TEL AVIV, Israel and BETHESDA, Maryland, Sept. 24, 2018 /PRNewswire/ -- CANNABICS PHARMACEUTICALS INC. (OTCQB: CNBX) ("Cannabics" or the "Company"), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced it has entered into definitive agreements with investors for the purchase and sale of (i) 10,000,000 shares of common stock, par value $0.0001 per share, and (ii) warrants to purchase up to 5,000,000 shares of common stock at a combined offering price of $0.75 per share and warrant, pursuant to a registered direct offering. The warrants will have an exercise price of $1.00 per share, will be immediately exercisable and will expire five years from the date of issuance. The gross proceeds of the offering will be approximately $7,500,000 before deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds for working capital and other general corporate purposes. The closing of the registered direct offering is expected to take place on or about Sept. 26, 2018, subject to the satisfaction of customary closing conditions.
- Shareholder Update: Creative Medical Technology Holdings, Inc.
PHOENIX, Sept. 24, 2018 /PRNewswire/ -- (OTCQB-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its progress:
Debt: We have entered into an agreement with three institutional investors in order to wrap up existing debt and provide working capital. These parties intend to provide support to the company through its commercialization of the CaverStemTM program and for future programs being developed. An 8k is being prepared and will be filed in the coming days specifying the terms. The agreement comes with better terms than were previously available and is expected to provide the necessary funding until which time as the company is generating sufficient cash flow to support operating activities.
- Q Biomed Inc. Announces Entry Into Definitive Funding Agreement for $4,000,000
Financing Provides Necessary Capital to Reach Important Milestones
NEW YORK, September 24, 2018 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO), is pleased to announce that it has entered into a definitive agreement with Yorkville Advisors Global ('Yorkville') for $4,000,000.
Q BioMed has closed on the initial tranche of $2,000,000 and expects to close on the balance pending the filing of a registration statement with the U.S. Securities and Exchange Commission for the underlying shares.
- Terra Tech Corp. Granted Phase I Cultivation, Manufacturing and Distribution Permits for its Three Santa Ana, CA Locations
Company to commence build-out of cultivation and extraction facilities, which is expected to drive growth in its ‘IVXX’ wholesale business and support full vertical-integration at its Southern California operations
IRVINE, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC), (“Terra Tech” or the “Company”) a vertically integrated cannabis-focused agriculture company, is pleased to announce that the City of Santa Ana has granted its East Dyer Road, East Carnegie Avenue and South Tech Center Drive locations vertically-integrated Phase I permits. These permits allow the Company to commence development of cultivation, manufacturing and distribution capabilities at these locations. Moreover, upon completion of the build-out of each location’s facilities, they also confer upon the Company the right to apply for Phase II permits which are needed to commence commercial activities.
- The March of Artificial Intelligence and Robotics; Rapid Progress and Big Spending Shaping an Economy of the Future
NEW YORK, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Investorideas.com, a leader in investor news and research in leading sectors releases a sector snapshot on the AI and Robotics market with commentary and recent news from industry experts including the CTO of Gopher Protocol Inc. (OTCQB: GOPH) discussing the company’s recent white paper on the Avant! AI system and also commenting on the recent DARPA news.
Connect with 24/7 Market News on social media:
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.
24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. 24/7MN owns KBLB shares that it can sell at any time. 24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.
For further information on 24/7 Market News, please go to www.247marketnews.com
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements
24/7 Market News